Environmental Enteric Dysfunction Includes a Broad Spectrum of Inflammatory Responses and Epithelial Repair Processes

Cellular and Molecular Gastroenterology and Hepatology

Volumn 2, Issue 2, 2016, Pages 158-174.e1

  Yu, Jinsheng ^a   Ordiz, M Isabel ^a   Stauber, Jennifer ^a   Shaikh, Nurmohammad ^a   Trehan, Indi ^a   Barnell, Erica ^a   Head, Richard D ^a   Maleta, Ken ^b   Tarr, Phillip I ^a   Manary, Mark J ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Environmental Enteropathy; Fecal Transcriptome; Intestinal Inflammation; Stunting

Indexed keywords

B CELL ACTIVATING FACTOR; CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; SMALL NUCLEOLAR RNA; TRANSCRIPTOME;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CARBOHYDRATE ABSORPTION; CELL ADHESION; CHILD; COHORT ANALYSIS; DISEASE SEVERITY; ENTERITIS; ENVIRONMENTAL ENTERIC DYSFUNCTION; FECES; FEMALE; GENE DOSAGE; HUMAN; IMMUNE RESPONSE; LOOSE FECES; MAJOR CLINICAL STUDY; MALAWI; MALAWIAN; MALE; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RNA SEQUENCE; RURAL POPULATION; STUNTING;

EID: 84975770278     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2015.12.002     Document Type: Article

References (44)

1. UNICEF. Improving child nutrition. 1, 8-14 (2013). Available from: . http://www.unicef.it/Allegati/Improving_Child_Nutrition.pdf.
2. Black R.E., Allen L.H., Bhutta Z.A., et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008, 371:243-260. Maternal and Child Undernutrition Study Group.
3. Keusch G.T., Rosenberg I.H., Denno D.M., et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull 2013, 34:357-364.
4. Humphrey J.H. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009, 374:1032-1035.
5. Korpe P.S., Petri W.A. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 2012, 18:328-336.
6. Kosek M., Guerrant R.L., Kang G., et al. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Clin Infect Dis 2014, 59:S207-S212. MAL-ED Network Investigators.
7. Denno D.M., VanBuskirk K., Nelson Z.C., et al. Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review. Clin Infect Dis 2014, 59:S213-S219.
8. Chu Y., Corey D.R. RNA sequencing: platform selection, experimental design, and data interpretation. Nucleic Acid Ther 2012, 22:271-274.
9. Weisz A.J., Manary M.J., Stephenson K., et al. Abnormal gut integrity is associated with reduced linear growth in rural Malawian children. J Pediatr Gastroenterol Nutr 2012, 55:747-750.
10. Lunn P.G., Northrop-Clewes C.A., Downes R.M. Intestinal permeability, and growth faltering in Gambian infants. Lancet 1991, 338:907-910.
11. Smith M.I., Yatsunenko T., Manary M.J., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013, 339:548-554.
12. Ryan K.N., Stephenson K.B., Trehan I., et al. Zinc or albendazole attenuates the progression of environmental enteropathy: a randomized controlled trial. Clin Gastroenterol Hepatol 2014, 12:1507-1513.
13. Smith H.E., Ryan K.N., Stephenson K.B., et al. Multiple micronutrient supplementation transiently ameliorates environmental enteropathy in Malawian children aged 12-35 months in a randomized controlled clinical trial. J Nutr 2014, 144:2059-2065.
14. Schulman R.J., Eakin M.N., Czyzewski D.I., et al. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 2008, 153:646-650.
15. Trehan I., Shulman R.J., Ou C.N., et al. Double-blind, placebo-controlled trial of rifaximin, a non-absorbable antibiotic, in the treatment of sub-clinical tropical enteropathy. Am J Gastroenterol 2009, 104:2326-2333.
16. Schuurman T., De Boer R.F., van Deursen P.B.H., et al. P582 Highly efficient extraction of pathogen DNA from stool using the NucliSENS easyMAG TM specific A 1.0.2 protocol. Int J Antimicrobial Agents 2007, 29:S134.
17. Shulman L.M., Hindiyeh M., Muhsen K., et al. Evaluation of four different systems for extraction of RNA from stool suspensions using MS-2 coliphage as an exogenous control for RT-PCR inhibition. PLoS One 2012, 7:e39455.
18. Dundas N., Leos N.K., Mitui M., et al. Comparison of automated nucleic acid extraction methods with manual extraction. J Mol Diagn 2008, 10:311-316.
19. Loens K., Bergs K., Ursi D., et al. Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens. J Clin Microbiol 2007, 45:421-425.
20. Victoria J.G., Kapoor A., Li L., et al. Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis. J Virol 2009, 83:4642-4651.
21. Agapova S., Stephenson K., Manary M., et al. Detection of low-concentration host mRNA transcripts in Malawian children at risk for environmental enteropathy. J Pediatr Gastroenterol Nutr 2013, 56:66-71.
22. McDermott G.P., Do D., Litterst C.M., et al. Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR. Anal Chem 2013, 85:11619-11627.
23. Henrich T.J., Gallien S., Li J.Z., et al. Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J Virol Methods 2012, 186:68-72.
24. Affymetrix. DataSheet GeneChip® Human Transcriptome Array 2.0. Available from: . http://media.affymetrix.com/support/technical/datasheets/hta_array_2_0_datasheet.pdf.
25. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
26. Welsh E.A., Eschrich S.A., Berglund A.E., et al. Iterative rank-order normalization of gene expression microarray data. BMC Bioinformatics 2013, 14:153.
27. Hochreiter S., Djork-Arne C., Obermayer K. A new summarization method for Affymetrix probe level data. Bioinformatics 2006, 22:943-949.
28. Ritchie M.E., Phipson B., Wu D., et al. Limma powers differential expression analysis for RNA-sequencing and microarray studies. Nucleic Acids Res 2015, 43:e47.
29. Ekins S., Nikolsky Y., Bugrim A., et al. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007, 356:319-350.
30. Luo W., Friedman M., Shedden K., et al. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 2009, 10:161.
31. Affymetrix. Human transcriptome array 2.0-support materials. Sample data WT PLUS HTA 2.0 data on tissue panel samples (zip, 756 MB). Available from: . http://www.affymetrix.com/support/technical/byproduct.affx?product=human_transcriptome.
32. Chapkin R.S., Zhao C., Ivanov I., et al. Noninvasive stool-based detection of infant gastrointestinal development using gene expression profiles from exfoliated epithelial cells. Am J Physiol Gastrointest Liver Physiol 2010, 298:582-589.
33. Knight J.M., Davidson L.A., Herman D., et al. Non-invasive analysis of intestinal development in preterm and term infants using RNA-Sequencing. Sci Rep 2014, 4:1-9.
34. Corner R.S., Lausen B., Schellerer, et al. Comparability of microarray data between amplified and non-amplified RNA in colorectal carcinoma. J Biomed Biotechnol 2009, 2009:837170.
35. Bennett W.E., González-Rivera R., Puente B.N., et al. Proinflammatory fecal mRNA and childhood bacterial enteric infections. Gut Microbes 2010, 1:209-212.
36. Gardner J.C., Noel J.G., Nikolaidis N.M., et al. G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol 2014, 192:2405-2417.
37. Jung E., Perrone E.E., Brahmamdan P., et al. Inhibition of intestinal epithelial apoptosis improves survival in a murine model of radiation combined injury. PLoS One 2013, 8:e77203.
38. Kim J.S., Yang M., Lee C.G., et al. In vitro and in vivo protective effects of granulocyte colony-stimulating factor against radiation-induced intestinal injury. Arch Pharm Res 2013, 36:1252-1261.
39. Zhang C., Xu Y.G., Duan X.N., et al. Role of granulocyte colony-stimulating factor in paclitaxel-induced intestinal barrier breakdown and bacterial translocation in rats. Chin Med J 2011, 124:1870-1875.
40. Prendergast A., Kelly P. Review: enteropathies in the developing world: neglected effects on global health. Am J Trop Med 2012, 86:756-763.
41. Moehle C., Ackermann N., Langmann T., et al. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 2006, 84:1055-1066.
42. Pelaseyed T., Bergström J.H., Gustafsson J.K., et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of gastrointestinal tract and interact with the immune system. Immunol Rev 2014, 260:8-20.
43. Hickey C.A., Kuhn K.A., Donermeyer D.L., et al. Colitogenic bacteroides thetaiotaomicron antigens access host immune cells in a sulfatase-dependent manner via outer membrane vesicles. Cell Host Microbe 2015, 17:672-680.
44. Holtz L.R., Cao S., Zhao G., et al. Geographic variation in the eukaryotic virome of human diarrhea. Virology 2014, 468-470:556-564.